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Background: The influence of occupation and ex/passive smoking on inflammatory phenotype is not well
understood. The aim of this study was to examine the relationship between occupation, past smoking and current
passive smoking and airway inflammation in a population of adults with refractory asthma.
Methods: Sixty-six participants with refractory asthma were characterised. Occupational exposure to asthma
causing or worsening agents were identified with an asthma-specific job exposure matrix. Exposure to passive
cigarette smoke was determined by questionnaire and exhaled carbon monoxide assessment. The carbon content
of macrophages was assessed in a sub-group of participants.
Results: Nineteen participants had smoked previously with low smoking pack years (median 1.7 years). Ex-smokers
more commonly lived with a current smoker (26% vs. 9%, p = 0.11) and were more likely to allow smoking inside
their home (26% vs. 4%, p = 0.02) compared to never smokers. Twenty participants had occupations with an identified
exposure risk to an asthmagen; thirteen had exposures to irritants such as motor vehicle exhaust and environmental
tobacco smoke. Sputum neutrophils were elevated in participants with asthma who had occupational exposures,
particularly those who were diagnosed with asthma at a more than 30 years of age.
Conclusions: Sputum neutrophils are elevated in refractory asthma with exposure to occupational asthmagens. In
addition to older age, exposure to both environmental and occupational particulate matter may contribute to the
presence of neutrophilic asthma. This may help explain asthma heterogeneity and geographical variations in airway
inflammatory phenotypes in asthma.
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Asthma is a common and chronic disorder of the air-
ways induced by multiple stimuli including exposure to
allergens, particulates and infectious agents. The inflam-
matory pattern observed in asthma is heterogeneous [1]
and non-eosinophilic inflammatory patterns while com-
mon, are not responsive to inhaled corticosteroid therapy
[2,3]. The triggers of non-eosinophilic airway inflamma-
tion in asthma remain elusive and approximately 40% of
adults with non-eosinophilic asthma have neutrophilic
bronchitis with increased expression of neutrophil cyto-
kines and proteases [4]. In community sampling, increased* Correspondence: jodie.simpson@newcastle.edu.au
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unless otherwise stated.respiratory symptoms have been associated with occupa-
tional exposures [5] and workplace-exacerbated asthma is
associated with a non-eosinophilic phenotype [6]. Know-
ledge is scant about the influence of occupational expo-
sures on airway inflammation in patients with refractory
asthma.
Work related asthma includes patients with sensitiser or
irritant-induced asthma in the workplace (termed occupa-
tional asthma), as well as patients with pre-existing asthma
worsened by work exposures (workplace-exacerbated
asthma) [7]. In workplace-exacerbated asthma, patients
have pre-existing or concurrent asthma that worsens by
exposure to irritants, aeroallergens, changes in tempera-
ture or exercise [8-11]. Approximately 20% of working
adults may have workplace-exacerbated asthma [12] and
they experience more symptoms, require more medical
care and have a reduced quality of life [13].al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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proving our understanding of the role of asthmagens in
exacerbating symptoms of those already diagnosed with
refractory asthma. Also in clinical trials designed to test
the effectiveness of a new treatment modality, exposure
to a workplace asthmagen may be a significant con-
founding factor for consideration.
The employment history of individuals often involves
the changing of jobs or occupations, differing environ-
ments, varying levels of exposure and multiple sources
of exposure over a lifetime. These present challenges to
researchers engaging in exposure assessment and have
limited the ability to establish firm cause and effect
models [14]. Despite these challenges, many studies have
established systematic approaches focusing on lifetime
occupational exposures using Job Exposure Matrices
[15,16]. The most widely used job exposure matrix in
asthma research is an asthma-specific job exposure
matrix (AsthmaJEM) [17,18].
In this study, we examined the relationship between
occupational exposure to asthmagens, tobacco smoke
exposure and airway inflammation in adults with refrac-
tory asthma. We tested the hypothesis that patients with
asthma exposed to occupational asthmagens would be
more likely to have neutrophilic bronchitis than those
without exposure and that exposure to passive cigarette
smoke would result in a worsening of neutrophilic
bronchitis.Methods
Study participants
Adults with refractory asthma [19] were recruited from
the Ambulatory Care Service of the Department of Re-
spiratory and Sleep Medicine at the John Hunter Hos-
pital (New Lambton Heights, NSW, Australia) between
2004 and 2006. Participants comprised part of the
screening population from a previous study [20]. Partici-
pants were excluded if they were currently smoking, had
an exacerbation of their asthma or required antibiotics
in the past four weeks. The Hunter Area Health Service
and The University of Newcastle Human Research Eth-
ics Committees approved this longitudinal study.Clinical assessments
Participants reported smoking history and passive smok-
ing exposures. The asthma control score [21] and quality-
of-life score [22] were assessed. Spirometry (KoKo PD
Instrumentation, Louisville, CO, USA), combined bron-
chial provocation testing and sputum induction with
hypertonic saline (4.5%) were performed. Sputum selected
from saliva was dispersed using dithiothreitol, the suspen-
sion was filtered and a total cell count and viability of leu-
cocytes ascertained [23]. Cytospins were prepared andstained with May-Grünwald Giemsa stain and a differen-
tial cell count was obtained from 400 non-squamous cells.
Passive and active smoking exposures
Smoking status was assessed by questionnaire [24], ex-
haled carbon monoxide (eCO) and cotinine by reagent
strip (NicAlert™, Nymox Pharmaceutical Corporation,
St.-Laurent QC, Canada) [25]. All included participants
had an eCO of less than 10 ppm confirming their
current non-smoking status [26].
Carbon content of macrophages
May-Grünwald Giemsa stained slides from 29 partici-
pants were screened under a 100X oil objective using an
Olympus BX61 microscope. Photographs of 50 macro-
phages were then taken from each slide and used for
analysis using ImageJ software [27]. Macrophages were
not selected based on the presence of carbon particles,
rather, once a macrophage was identified then a further
50 macrophages were assessed as they were identified in
each field of view. Each macrophage image was cropped
and converted into a black and white image with the car-
bon particles considered the darkest particles. The num-
ber, size and area of carbon particles were determined.
Inflammatory phenotype
Participants were categoriesed according to granulocytic
inflammatory phenotype as follows: eosinophilic (eosin-
ophils >3%), neutrophilic (neutrophils >61%), paucigra-
nulocytic (eosinophils <3% and neutrophils <61%) and
mixed granulocytic (eosinophils >3% and neutrophils
>61%) [1,28].
Occupational exposures
A full occupational history was recorded by question-
naire at interview, with information relating to position,
industry and calendar year at the beginning and end of
the occupation. All jobs with duration of at least three
months were recorded. A six-digit code (Australian
Standard Classification of Occupation) was assigned by
an experienced coder using a coding program developed
by the Australian Bureau of Statistics [29]. Jobs were
subsequently translated into a four-digit code (Inter-
national Standard Classification of Occupations 1988)
utilising a concordance tool supplied by the Australian
Bureau of Statistics. Jobs were linked to estimates of ex-
posure to 22 agents using an asthma-specific job expos-
ure matrix (AsthmaJEM) [17].
The AsthmaJEM was first merged on job codes to
evaluate exposure (yes/no) to each of the 22 agents for
each reported job. Exposures to 18 known asthmagens
and four work environments with exposure to irritants
or with low level exposure to chemicals or allergens were
evaluated. Examples of the most frequent occupational
Table 1 Descriptive statistics of demographic and clinical







Age (years) 59.9 49.2 – 65.7 66
Female 34 52% 66
Age of asthma
diagnosis (years)
18.5 6.0 – 42.0 66
Currently Employed 43 65% 66
Ex-smoker 19 29% 66
Ex-smoker Pack years 1.7 0.50 – 5.00 19
Atopic asthma 50 76% 66
Past 12 months unscheduled
doctors visit
38 58% 66






Asthma control score (ACQ) 1.41 1.00 – 2.14 66
Quality of Life Total Score 5.71 4.81 – 6.44 66
FEV1% predicted 69.4 53.0 – 82.4 66
FEV1/FVC 66.7 58.0 – 76.0 66
ICS dose/1000 (mg/day)† 2 1 – 2 65
PD15
‡ 4.84 1.39 – 14.26 42
Dose response slope* 2.59 0.76 – 5.59 53
Count and percentage displayed for categorical variables and median and
IQR otherwise.
†Inhaled corticosteroids normalisation: 1 μg beclomethasone = 1 μg budesonide =
0.5 μg fluticasone.
‡PD15: provocation dose causing fall in FEV1 of ≥15% from baseline.
*Dose response slope: % fall FEV1/mL 4.5% saline.
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aerosols, highly reactive chemicals, industrial cleaning
agents, metal sensitisers, metal working fluids environ-
ments and textile production.
Job history information was used to create a dataset
that assessed occupational exposure. Exposure was de-
fined as the maximum exposure level of the study par-
ticipant over their working life to one of five groups:
1. High-risk exposure to high molecular weight
(HMW ≥1000 kD) agents (protein-derived agents)
2. High-risk exposure to low molecular weight
(LMW ≤1000 kD) agents (reactive chemicals)
antigens
3. High risk exposure to mixed environments or agents
4. Low risk possible exposure to other respiratory
hazards
5. Not exposed (reference group)
Statistical methods
Descriptive statistics are reported as counts and percent-
ages for categorical variables and median and interquartile
range (IQR) (25th percentile-75th percentile) for continu-
ous variables. Fisher’s exact test was used to test for a
univariate association of occupational exposure to any cat-
egorical variable. Wilcoxon rank-sum test was used to test
for a univariate association of occupational exposure and
Kruskal-Wallis test for diagnosis age and exposure to any
continuous variable. Multivariable linear regression, with a
random effect for participant, was used with the specific
objective of detecting an association between exposure
probability and clinical and inflammatory markers. Insig-
nificant variables were removed from the full model to ob-
tain the simplest model with greatest explanatory power.
Significance was determined at the 5% level. All data ma-
nipulation and analysis were performed in Stata/MP Ver-
sion 12 [30].
Results
Sixty-six eligible participants participated in the study.
Table 1 reports detailed demographic and clinical sum-
mary statistics. Participants were middle aged (median
60 years), atopic (76%) adults with moderate-severe air-
flow obstruction without well-controlled asthma (asthma
control score >0.75) [31], despite being prescribed a high
dose of inhaled corticosteroids (ICS) (median 2000 μg
daily) consistent with a diagnosis of refractory asthma.
Active and passive smoking exposures
Nineteen (29%) participants had previously smoked,
however with relatively low smoking pack years of 1.7
(IQR 0.5 - 5). Most participants allowed smoking outside
of their homes and ex-smokers were significantly more
likely to allow smoking inside their home compared tonever smokers. Spending time in smoky places outside
of the participants’ home was common and not different
between ex-smokers and never smokers (Table 2).
Occupational exposures
Table 3 shows the occupations of participants and po-
tential exposures according to AsthmaJEM [17]. Of the
66 participants, 46 (69.7%) had no exposure to any iden-
tified asthmagen, holding occupations such as school-
teacher, office clerk or sales assistant. Of the remaining
20 participants, 11 had occupations with high-risk expo-
sures to asthmagens, such as latex, cleaning products
and wood dust, leaving nine participants with low risk
exposures such as exhaust fumes. The single category with
the highest number of participants was those exposed to
motor exhaust fumes with nine (45%) of the 20 partici-
pants identified as having exposure to asthmagens.
Some occupations encounter more than a single ex-
posure and therefore participants may have exposures to
more than one agent. In this study we found 4 partici-
pants with two exposures and a further 4 with three ex-
posures. This means that the total in Table 3 is greater
Table 2 Characteristics of active and passive smoking




N = 47 N = 19
Median IQR
Smoking (pack-years) 1.70 0.5 – 5.00
Passive smoking
at home
Lives with one or
more smokers
4 9% 5 26% 0.108
Smoking not allowed
in home
12 23% 1 5% 0.156
Smoking allowed inside 2 4% 5 26% 0.018
Smoking allowed outside 34 72% 13 68% 0.770
Passive smoking
elsewhere
No time with smokers 18 38% 4 21% 0.252
Spends time indoors
smokers
6 13% 3 16% 0.709
Spends time outdoors
smokers
22 47% 12 63% 0.283
Median IQR Median IQR
Smoking biomarkers
eCO (ppm) 2 1 - 3 2 1 – 3 0.751
NicAlert™ 1 1 - 1 1 0 – 2 0.441
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the highest number of exposures were cleaner, personal
care worker, farmer and machine-tool operator.
Table 4 shows descriptive statistics of clinical out-
comes and inflammatory markers by exposure and diag-
nosis age (30+ or <30 years of age at diagnosis). The
dichotomised age of diagnosis was significantly related
to exposure (Odds Ratio 3.4, P = 0.03), with an older age
of diagnosis in the exposed group. Higher percentages of
neutrophils are seen in the exposed groups, 27 versus
47% in the 30+ diagnosis age group and 42 versus 51%
in the younger diagnosis age group, although the differ-
ence does not reach statistical significance with this
small sample size. Participants diagnosed with asthma
before the age of 30 had worse lung function (lower
FEV1% predicted and FEV1/FVC), more airways hyperre-
sponsiveness (lower PD15 and higher dose response
slope) and were more likely to be atopic compared to
those participants with refractory asthma who were diag-
nosed at more than 30 years of age (Table 4).
Multivariable linear regression models were fit to as-
sess the effect of possible confounders, such as age, gen-
der and smoking characteristics, on the relationships
between exposures and sputum inflammatory cells. More
precisely, sputum neutrophils, eosinophils, macrophagesand lymphocytes were examined and for each of these a
model was fit including one of four exposure variables
(high weight, low weight, mixed and all), the possible con-
founders and their interactions as explanatory variables.
The aim of was to find any significant association between
an exposure variable and a single inflammatory cell type.
Of the many models fitted, only exposure, diagnosis age
and age had a significant effect on sputum neutrophils. Of
the different types of exposures, only combined exposure,
that is, exposure to any agent, reached statistical signifi-
cance in any model. Consequently, in the results detailed
below, “exposure” means “exposure to any agent”.
The percentage of neutrophils was significantly af-
fected by exposure, as were age (P = 0.001) and diagnosis
age (a square root transform applied to the response to
improve the normality of the residuals). In this model no
smoking characteristics were significant (all P > 0.1) and
neither was gender (P = 0.5). There were no significant
interactions between exposure, diagnosis-age and age (P >
0.3). There was a significant interaction between age and
the dose of inhaled corticosteroid (P = 0.007), for which
the coefficient was negative, indicating that the effect of
inhaled corticosteroids on neutrophil proportion is less at
older ages. Being diagnosed with asthma over the age of
30 and having an occupational exposure was associated
with a 20% increase in neutrophils compared to those
without an occupational exposure.
Figure 1 shows the estimated average neutrophil per-
centage by age for exposure and diagnosis age groups.
The difference between the exposed and unexposed in
the diagnosis age group 30+ was significant (P = 0.032),
but not the difference between exposed and unexposed
in the younger diagnosis age group (P = 0.13). The aver-
age increase in neutrophil percentage associated to ex-
posure is 20% in those diagnosed after the age of 30.
The average increase in neutrophil percentage associated
to exposure is 10% in those diagnosed under the age of
30 years. Neutrophil proportion increases with age at
the rate of 0.5% per year of age. These results are dis-
played in Figure 1 for a dose of 2000 μg beclomethasone
equivalents (see Figure 1).
Discussion
This study examined the relationship between occupa-
tional exposures to asthmagens, age at diagnosis and
airway inflammation in a population of adults with re-
fractory asthma. We sought to test the hypothesis that
patients with refractory asthma exposed to occupational
asthmagens would be more likely to have neutrophilic
bronchitis than those without exposure. We found that
approximately one third of adults with poorly controlled
asthma had occupations with identifiable exposures to
occupational asthmagens whose symptoms may exacer-
bate or worsen their asthma. A diagnosis of asthma at
Table 3 Occupations of participants with exposures to asthmagenic agents according to AsthmaJEM (N = 66)
Level of risk Agents Total N N Occupations
High risk High molecular weight
Animals 1 1 Dairy and livestock producers
Latex 2 1 Nursing and midwifery professionals
1 Institution-based personal care workers
Bioaerosols 2 1 Dairy and livestock producers
1 Machine-tool operators
Total number with a high molecular weight exposure 4*
Low molecular weight
Highly reactive chemicals 3 1 Biologists, botanists, zoologists and related professionals
1 Institution-based personal care workers
1 Helpers/cleaners in offices, hotels etc.
Industrial cleaning products 2 1 Institution-based personal care workers
1 Helpers/cleaners in offices, hotels etc.
Wood dusts 1 1 Carpenters and joiners
Metal sensitizers 2 1 Tool-makers and related workers
1 Machine-tool operators
Total number with a low molecular weight exposure 6*
Mixed environments or agents
Metal working fluids 2 1 Tool-makers and related workers
1 Machine-tool operators
Agricultural 1 1 Dairy and livestock producers
Textiles 1 1 Tailors, dressmakers and hatters
High irritant peaks 2 2 Police officers
Total number with exposure to mixed environments or agents 6*
Total number with a high risk exposure 11*
Low risk Possible exposure to other respiratory hazards
Irritants, but not high peaks 3 1 Carpenters and joiners
1 Mining-plant operators
1 Helpers/cleaners in offices, hotels etc.
Motor vehicle exhaust fumes 9 2 Police officers
1 Motor mechanics and fitters
1 Railway brakers, signallers and shunters
3 Car, taxi and van drivers
1 Bus and tram drivers
1 Lifting-truck operators
Environmental tobacco smoke 1 1 Waiters, waitresses and bartenders
Total number with exposure to other respiratory hazards 13*
Total number with a low risk exposure 9
No risk Total number with no exposure to any respiratory hazard 46
*Totals do not add since some participants had multiple exposures and/or multiple occupations.
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crease in sputum neutrophils and 70% of participants in
the exposed group showed evidence of airway inflamma-
tion, half of those with neutrophilic bronchitis.The findings of the European Community Respiratory
Health Surveys I and II investigated the association be-
tween occupational exposure and adult-onset asthma
and asthma control. Survey I found that uncontrolled










Observed first visit N = 14 N = 12 N = 32 N = 8
Age 14 63 (60-69) 12 64 (62-69) 32 53 (44-63) 8 46 (37-52)
Female 14 9 (64%) 12 4 (33%) 32 19 (59%) 8 2 (25%)
Currently Employed 14 6 (43%) 12 6 (50%) 32 24 (75%) 8 7 (88%)
Years at work 14 30 (30-35) 12 30 (20-30) 32 25 (19-33) 8 25 (15-26)
Ex-smoker 14 5 (36%) 12 2 (17%)** 32 7 (22%) 8 5 (63%)**
Smoking at home 14 2 (14%) 12 2 (17%) 32 3 (9%) 8 0 (0%)
Smoky places 14 7 (50%) 11 8 (73%) 32 20 (63%) 8 8 (100%)** X
Atopic 14 6 (43%) 12 9 (75%) 32 28 (88%) 8 7 (88%)XX AA
ICS dose/1000 14 2 (1.6-2.0) 12 2 (0.9-2.0) 31 2 (0.6-2.0) 8 2 (1.0-2.0)
%Macrophages w carbon inclusion 1 30 5 46 (46-48) 7 30 (20-52) 1 42
# Carbon inclusions/macrophage 1 2 5 4 (4.0-5.0) 7 3 (2-6) 1 4
Total number Carbon inclusions 1 57 5 184 (160-212) 7 107 (27-224) 1 186
Obs. multiple visits N = 22 N = 20 N = 71 N = 14
FEV1% predicted 17 82 (59-88) 16 75 (64-84) 46 63 (48-79) 10 74 (67-83)
X AA
FEV1/FVC 17 76 (64-80) 16 71 (67-77) 46 64 (56-69) 10 69 (63-71)
XX AA
PD15 10 15 (12-29) 5 21 (19-34) 32 5 (1.1-8.6) 8 2 (1.3-6.5)
XX AA
Dose response slope 14 1 (0.5-2.2) 11 0 (0.2-0.8) 41 3 (1.2-11.5) 9 6 (2.1-8.6)XX AA
Total cell # ×106/mL 21 3 (2.1-3.6) 20 6 (2.7-10.6) 69 3 (2.1-7.8) 14 3 (1.8-7.2)
Macrophages, % 22 51 (28-72) 20 28 (15-51) 71 44 (20-61) 14 44 (28-52)
Neutrophils, % 22 27 (14-40) 20 47 (37-74) 71 42 (27-72) 14 51 (36-67)XX
Lymphocytes, % 22 1 (0.0-2.0) 20 0 (0.0-1.1) 71 1 (0.3-2.0) 14 0 (0.0-1.3)
Eosinophils, % 22 1 (0.3-3.3) 20 2 (0.9-9.9) 71 1 (0.3-2.8) 14 1 (0.3-1.8)
Col. epithelial cells, % 22 6 (1.5-12.8) 20 3 (0.8-7.0) 71 3 (1.5-5.9) 14 4 (2.5-7.3)
Squamous cells, % 22 5 (1.5-11.3) 20 2 (0.9-4.4) 71 3 (1.0-6.1) 14 5 (1.2-9.5)
Test of effect of exposure in each diagnosis age group: **significant P < 0.05. Fisher’s exact and rank-sum tests used.
Test of effect of exposure and diagnosis age group: Xmarginally significant P < 0.10, XXsignificant P < 0.05. Fisher’s exact and Kruskal-Wallis tests used.
Test of effect of diagnosis age group only: AAsignificant P < 0.05. Fisher’s exact and rank-sum tests used.
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to an occupational asthmagen (and more so if the expos-
ure was long term) and that the association was predom-
inantly explained by the exacerbation domain suggesting
those with exposure to occupational asthmagens experi-
ence more asthma exacerbations [15] Survey II, which
investigated the association between 12 month and
10 year occupational exposures and adult-onset asthma
have been published finding that the association was
stronger for long-term exposures [15].
The role of neutrophils in asthma is controversial. We
and others have reported the presence of neutrophilic
asthma subtypes in adults with these participants being
significantly older than those with normal proportions of
neutrophils [1]. In adults, sputum neutrophils are associ-
ated with age and a neutrophilic phenotype of asthma is
evident in older age even after correcting for the age
related increase in neutrophils [32], suggesting there issomething in addition to the effect of ageing that ele-
vates sputum neutrophils in asthma. Smoking is an obvi-
ous consideration as it is known to induce a neutrophilic
inflammation that can persist despite cessation, however
in this study participants had smoked very little and
current smoking or excessive past smoking is unlikely to
have influenced sputum neutrophilic inflammation.
The influence of passive smoking on airway inflamma-
tion in asthma is less clear, especially in adults. In this
study we observed that participants were generally toler-
ant of others smoking outside their homes and many
spent time outdoors with smokers indicating the poten-
tial for significant passive smoking exposure. Ex-smokers
were more likely to allow smoking inside their homes
and often lived with other smokers, so despite not ac-
tively smoking these participants may have exposure to
more environmental tobacco smoke. Exposure to environ-
mental tobacco smoke has been associated with increased
Figure 1 Observed neutrophils (%) and estimated mean neutrophils (%) at corticosteroid dose 2000 μg, by age, diagnosis age group
and occupational exposure (126 observations on 65 participants).
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cigarettes [33], suggesting that exposure to passive smoke
can influence airway inflammation and further studies are
needed to understand the long term effects of exposure to
environmental tobacco smoke exposure in adults with
asthma.
Motor exhaust fumes were the most common expos-
ure identified from the participants’ occupation analysis.
This may represent a common exposure in adults with
neutrophilic bronchitis as exposure to diesel exhaust can
result in a neutrophilic infiltrate even in healthy individ-
uals [34]. Exposure to motor exhaust fumes that result
from living in close proximity to a highway or major
road not only increases asthma risk but is also associated
with neutrophilic bronchitis. Indeed the study of Wallace
et al demonstrated that those living within 1 km of a
major road were 4.7 times more likely to have neutrophilic
bronchitis [35]. Similarly workplace-exacerbated asthma is
more commonly associated with engine exhaust fumes
than those with occupational asthma [6,36]. While neutro-
philic asthma is common [37-39], in some centres very
few patients exhibit neutrophilic bronchitis [40]. Rossall
et al compared the neutrophil counts in early- and late-
onset asthma patients, finding that raised sputum neutro-
phil counts were present in those study participants with
late-onset asthma, however not in healthy controls [41].
The authors went on to speculate that, as shown in earl-
ier studies, other factors such as environmental pollution
or infection were important in driving the neutrophilic
airway inflammation observed in late-onset asthma [42,43].
It is therefore possible that the common exposure may be
motor exhaust fumes from either residential exposureand/or occupational exposure and further work is needed
to examine this hypothesis.
Implications for clinical practice
Recently, numerous researchers [44,45] have suggested
that asthma relating to occupation often goes unrecog-
nised in clinical practice. While our research findings
are not able to attribute asthma causation to the occupa-
tional exposures reported, they do however highlight the
importance of taking into account that occupational ex-
posures can exacerbate existing asthma. In addition our
findings reinforce Cullinen and Cannon’s suggestion that
“it is good practice to enquire into the employment of
every working-age adult with asthma or rhinitis, particu-
larly in those presenting with new symptoms or symp-
toms that have become more difficult to manage”.
Patients should routinely be asked whether their symp-
toms improve when they are not at work” [45]. We
would suggest in addition that it would be prudent to
determine if the patient’s work includes exposure to
known asthmagens.
Implications for asthma patients
While some have postulated that occupational risk fac-
tors should be quickly identified to prevent uncontrolled
asthma others suggest that, at least for younger adults
with asthma, career choice should be an informed deci-
sion that takes into account their risks relating to
asthma control. Our finding that 30% of participants in
this study with refractory asthma had an occupation
with an exposure known to either be associated with
asthma risk or known to exacerbate existing asthma
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cupational exposures.
On the other hand, we found that the majority of
study participants had no identifiable risk and this may
represent the healthy worker effect, where the presence
of asthma has influenced job selection away from high-
risk jobs and that our findings may underestimate the
level of risk [44]. This is indeed an important point to
consider, especially in light of the recent findings of
Bhinder et al [46]. In a population of young Canadian
adults with asthma, knowledge relating to the occupa-
tional risks for asthma and high-risk occupations was
assessed, as well as their perception of the role of asthma
in career choice. They found that young adults with
asthma have suboptimal awareness of potential work-
related asthma risks. With their family physician being
most commonly the provider of their asthma care, few
young adults reported talking to their family physician
about the risks career choices could have on their
asthma. This observation represents an area of asthma
care that needs to be explored in young adults with
asthma.
Implications for researchers
The findings of this study highlight the importance of
assessing occupational exposures of patients participat-
ing in clinical trials because the effectiveness of any new
treatment modality may be underestimated if the role of
an occupational asthmagen goes unrecognised [47]. In
addition our study supports the recommendation by
Papadopoulos [47] that detailed phenotyping/endotyping
stands out as widely required in order to arrange or re-
categorize clinical syndromes into more coherent, uni-
form and treatment-responsive groups.
Study strengths and limitations
The strength of this study was the carefully characterised
asthma and analysis of sputum samples, eCO and pas-
sive smoking exposures for the 66 participants. A limita-
tion was the use of AsthmaJEM, which did not include a
breakdown of exhaust fumes into diesel and gasoline but
rather grouped all forms of exhaust singularly as exhaust
fumes. A further limitation is that all participants were
taking high doses of inhaled corticosteroids and further
studies are needed to determine the effect of occupa-
tional exposures in participants with milder disease who
do not require treatment with inhaled corticosteroids.
Inhaled corticosteroids are known to enhance the sur-
vival of airway neutrophils [48] and increase following
introduction of inhaled cortiocsteroids [40].
Conclusion
Sputum neutrophils are elevated in refractory asthma
with exposure to occupational asthmagens. In additionto older age, exposure to both environmental and occupa-
tional particulate matter may contribute to the presence of
neutrophilic asthma. This may help explain asthma het-
erogeneity and geographical variations in airway inflam-
matory phenotypes in asthma.
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